BioGaia AB (publ) (BIOG-B.ST)

SEK 101.1

(2.17%)

Long Term Debt Summary of BioGaia AB (publ)

  • BioGaia AB (publ)'s latest annual long term debt in 2023 was 26.35 Million SEK , up 436.45% from previous year.
  • BioGaia AB (publ)'s latest quarterly long term debt in 2024 Q3 was - SEK , down 0.0% from previous quarter.
  • BioGaia AB (publ) reported annual long term debt of 4.91 Million SEK in 2022, down -49.93% from previous year.
  • BioGaia AB (publ) reported annual long term debt of 9.81 Million SEK in 2021, down -52.51% from previous year.
  • BioGaia AB (publ) reported quarterly long term debt of - SEK for 2024 Q1, down 0.0% from previous quarter.
  • BioGaia AB (publ) reported quarterly long term debt of - SEK for 2024 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of BioGaia AB (publ) (2023 - 2002)

Historical Annual Long Term Debt of BioGaia AB (publ) (2023 - 2002)

Year Long Term Debt Long Term Debt Growth
2023 26.35 Million SEK 436.45%
2022 4.91 Million SEK -49.93%
2021 9.81 Million SEK -52.51%
2020 20.66 Million SEK 81.25%
2019 11.4 Million SEK 0.0%
2018 - SEK 0.0%
2017 - SEK 0.0%
2016 - SEK 0.0%
2015 - SEK 0.0%
2014 - SEK 0.0%
2013 - SEK 0.0%
2012 - SEK 0.0%
2011 - SEK 0.0%
2010 - SEK 0.0%
2009 - SEK 0.0%
2008 - SEK 0.0%
2007 - SEK 0.0%
2006 - SEK 0.0%
2005 - SEK 0.0%
2004 - SEK 0.0%
2003 - SEK -100.0%
2002 7.85 Million SEK 0.0%

Peer Long Term Debt Comparison of BioGaia AB (publ)

Name Long Term Debt Long Term Debt Difference
AcuCort AB - SEK -Infinity%
AlzeCure Pharma AB (publ) - SEK -Infinity%
Enzymatica AB (publ) 24.88 Million SEK -5.915%
Enorama Pharma AB (publ) 303 Thousand SEK -8598.35%
Gabather AB (publ) - SEK -Infinity%
Klaria Pharma Holding AB (publ.) - SEK -Infinity%
Moberg Pharma AB (publ) 3.46 Million SEK -660.196%
Nanexa AB (publ) 2.08 Million SEK -1162.865%
Newbury Pharmaceuticals AB (publ) - SEK -Infinity%
ODI Pharma AB - SEK -Infinity%
Orexo AB (publ) 448.4 Million SEK 94.122%
Probi AB (publ) 38.21 Million SEK 31.027%
Swedencare AB (publ) 1.44 Billion SEK 98.171%
Swedish Orphan Biovitrum AB (publ) 11.35 Billion SEK 99.768%
Toleranzia AB 850 Thousand SEK -3000.706%
Vivesto AB 5.18 Million SEK -408.705%